Targeting p53 by small molecule p53 activators in multiple myeloma

被引：0
|
作者：
Manujendra N Saha
Yijun Yang
Hong Chang
机构：
[1] University Health Network,Dept. of Laboratory Hematology
[2] Dept. of Laboratory Medicine and Pathobiology,undefined
[3] University of Toronto,undefined
来源：
Journal of Hematology & Oncology | / 5卷 / Suppl 1期
关键词：
Multiple Myeloma; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Chronic Lymphocytic Leukemia; TP53 Gene;
D O I：
10.1186/1756-8722-5-S1-A7
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Small molecule activators of the p53 response
    Ladds, Marcus J. G. W.
    Lain, Sonia
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2019, 11 (03) : 245 - 254
  • [2] Pilot screening programme for small molecule activators of p53
    Berkson, RG
    Hollick, JJ
    Westwood, NJ
    Woods, JA
    Lane, DP
    Lain, S
    INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (05) : 701 - 710
  • [3] Reviving the guardian of the genome: Small molecule activators of p53
    Nguyen, Daniel
    Liao, Wenjuan
    Zeng, Shelya X.
    Lu, Hua
    PHARMACOLOGY & THERAPEUTICS, 2017, 178 : 92 - 108
  • [4] Small molecule compounds targeting the p53 mutants
    Khadiullina, R.
    Mirgayazova, R.
    Davletshin, D.
    Khusainova, E.
    Chasov, V.
    Baud, M.
    Bulatov, E.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1407 - S1407
  • [5] Biological evaluation of novel small-molecule activators of p53
    Fedorova, Olga
    Daks, Alexandra
    Petukhov, Alexey
    Shuvalov, Oleg
    Vasileva, Elena
    Barlev, Nickolai
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S39 - S39
  • [6] p53 Abnormalities and Potential Therapeutic Targeting in Multiple Myeloma
    Teoh, P. J.
    Chng, W. J.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [7] Targeting p53
    Madrid, LV
    SCIENTIST, 1999, 13 (04): : 14 - 14
  • [8] Serum p53 oncoprotein and p53 antibodies as prognostic factors in multiple myeloma (MM).
    Pulkki, K
    Ollikainen, H
    Rajamaki, A
    Pelliniemi, TT
    BLOOD, 1995, 86 (10) : 242 - 242
  • [9] Reversal of p53 epigenetic silencing in multiple myeloma permits apoptosis by a p53 activator
    Hurt, Elaine M.
    Thomas, Suneetha B.
    Peng, Benjamin
    Farrar, William L.
    CANCER BIOLOGY & THERAPY, 2006, 5 (09) : 1154 - 1160
  • [10] Deletions of the p53 gene in multiple myeloma
    Drach, J
    Ackerman, J
    Kaufmann, H
    Königsberg, R
    Huber, H
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (04) : 886 - 886
12345